<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: fragile x syndrome</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Back to (brain) basics</title>
   	 <description>(PhysOrg.com) -- In his own words, MIT neuroscientist Mark Bear admits he did not "wake up one day and say 'Hey, I'm going to cure autism.'" But, after decades of painstaking basic research on how the brain rewires itself in response to external cues, Bear has discovered a way to reverse the symptoms of Fragile X Syndrome, a disorder that can cause autism, mental retardation and epilepsy.</description>
     <link>http://www.physorg.com/news176455642.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 03 Nov 2009 07:28:09 EST</pubDate>
	 <guid isPermaLink="false">news176455642</guid>
</item>
<item>
     <title>Clinical tests begin on medication to correct Fragile X defect</title>
   	 <description>NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability.  There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability, and optimal dosage in healthy volunteers.</description>
     <link>http://www.physorg.com/news176387082.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 02 Nov 2009 12:25:42 EST</pubDate>
	 <guid isPermaLink="false">news176387082</guid>
</item>
<item>
     <title>Trembling hands and molecular handshakes</title>
   	 <description>The heritable Fragile X tremor/ataxia syndrome is a common neurodegenerative disease. It is assumed to result from a relative lack of the protein Pur-alpha. A new study by a German team under the leadership of Dr. Dierk Niessing of the Helmholtz Zentrum Munchen and the Gene Center at Ludwigs-Maximilians-Universitaet in Munich provides important insights into the structure and function of this protein, which may lead to the development of a therapy.</description>
     <link>http://www.physorg.com/news175516941.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 23 Oct 2009 11:43:14 EST</pubDate>
	 <guid isPermaLink="false">news175516941</guid>
</item>
<item>
     <title>Could some forms of mental retardation be treated with drugs?</title>
   	 <description>Growth factors.  They are the proteins that trigger a countless number of actions in cells.  Drugs that increase or decrease certain growth factors have lead to treatments for cancer and cardiovascular diseases.   Georgetown University Medical Center researchers say a new understanding of a growth factor implicated in some mental retardation disorders could lead to a novel treatment.</description>
     <link>http://www.physorg.com/news175276262.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 20 Oct 2009 23:00:02 EST</pubDate>
	 <guid isPermaLink="false">news175276262</guid>
</item>
<item>
     <title>Chemists Rationally Design Inhibitors Against an RNA Molecule that Causes Myotonic Muscular Dystrophy</title>
   	 <description>(PhysOrg.com) -- Chemists at the University at Buffalo have used rational drug design to synthesize small, cell-permeable molecules that are effective in vitro against two common types of myotonic muscular dystrophy, a result that has implications for potentially curing muscular dystrophy, as well as other diseases. </description>
     <link>http://www.physorg.com/news168876812.html</link>
	 <category>Chemistry</category>
	 <pubDate>Fri, 07 Aug 2009 15:30:01 EST</pubDate>
	 <guid isPermaLink="false">news168876812</guid>
</item>
<item>
     <title>Measuring intellectual disability</title>
   	 <description>Researchers from the University of California, Davis have developed a specific and quantitative means of measuring levels of the fragile X mental retardation 1 (FMR1) protein (FMRP), which is mutated in fragile X syndrome.  The related report by Iwahashi et al, "A quantitative ELISA assay for the fragile X mental retardation 1 protein," appears in the July 2009 issue of the Journal of Molecular Diagnostics.</description>
     <link>http://www.physorg.com/news165038363.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 24 Jun 2009 05:10:01 EST</pubDate>
	 <guid isPermaLink="false">news165038363</guid>
</item>
<item>
     <title>Investigating a sometimes-faulty protein's role in brain links</title>
   	 <description>(PhysOrg.com) -- Researchers at MIT's Picower Institute for Learning and Memory have shed light on how a protein implicated in cognitive disorders maintains and regulates brain cell structures that are key to learning and memory. </description>
     <link>http://www.physorg.com/news160755604.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 05 May 2009 15:21:10 EST</pubDate>
	 <guid isPermaLink="false">news160755604</guid>
</item>
<item>
     <title>Small molecules might block mutant protein production  in Huntington's disease</title>
   	 <description>Molecules that selectively interfere with protein production can stop human cells from making the abnormal molecules that cause Huntington's disease, researchers at UT Southwestern Medical Center have found.</description>
     <link>http://www.physorg.com/news160591718.html</link>
	 <category>Biology</category>
	 <pubDate>Sun, 03 May 2009 18:04:49 EST</pubDate>
	 <guid isPermaLink="false">news160591718</guid>
</item>
<item>
     <title>Discovery could lead to new autism treatment</title>
   	 <description>A Brown University research team has discovered something in the brain that could serve as a target for future autism and mental retardation treatments.</description>
     <link>http://www.physorg.com/news152994663.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 04 Feb 2009 18:31:46 EST</pubDate>
	 <guid isPermaLink="false">news152994663</guid>
</item>
<item>
     <title>Research breakthrough targets genetic diseases</title>
   	 <description>(PhysOrg.com) -- A cure for debilitating genetic diseases such as Huntington`s disease, Friedreich`s ataxia and Fragile X syndrome is a step closer to reality, thanks to a recent scientific breakthrough.</description>
     <link>http://www.physorg.com/news151662099.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 20 Jan 2009 08:22:08 EST</pubDate>
	 <guid isPermaLink="false">news151662099</guid>
</item>
<item>
     <title>Biologists discover link between CGG repeats in DNA and neurological disorders</title>
   	 <description>Researchers have long known that some repetitive DNA sequences can make human chromosomes "fragile," i.e. appearing constricted or even broken during cell divisions. Scientists at Tufts University have found that one such DNA repeat not only stalls the cell's replication process but also thwarts the cell's capacity to repair and restart it. The researchers focused on this CGG repeat because it is associated with hereditary neurological disorders such as fragile X syndrome and FRAXE mental impairment.</description>
     <link>http://www.physorg.com/news150905205.html</link>
	 <category>Biology</category>
	 <pubDate>Sun, 11 Jan 2009 14:06:45 EST</pubDate>
	 <guid isPermaLink="false">news150905205</guid>
</item>
<item>
     <title>Promising new drug being evaluated as possible treatment option for fragile X syndrome</title>
   	 <description>A pilot trial of an oral drug therapy called fenobam has shown promising initial results and could be a potential new treatment option for adult patients with Fragile X syndrome (FXS).  Findings of the open label, single-dose study by researchers at Rush University Medical Center and the University of California, Davis, Medical Center are to be published in the upcoming January issue of the Journal of Medical Genetics.</description>
     <link>http://www.physorg.com/news150543311.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 07 Jan 2009 09:35:11 EST</pubDate>
	 <guid isPermaLink="false">news150543311</guid>
</item>


</channel>
</rss>

